Parabilis Medicines, Inc. (PBLS)
38.43
-0.93
(-2.36%)
USD |
NASDAQ |
Aug 24, 16:00
38.53
+0.10
(+0.26%)
After-Hours: 20:00
Parabilis Medicines Total Return Level : 38.43 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 38.43 |
| August 21, 2026 | 39.36 |
| August 20, 2026 | 39.58 |
| August 19, 2026 | 41.32 |
| August 18, 2026 | 39.35 |
| August 17, 2026 | 37.22 |
| August 14, 2026 | 37.07 |
| August 13, 2026 | 35.67 |
| August 12, 2026 | 37.41 |
| August 11, 2026 | 36.47 |
| August 10, 2026 | 35.73 |
| August 07, 2026 | 34.98 |
| August 06, 2026 | 35.58 |
| August 05, 2026 | 34.90 |
| August 04, 2026 | 35.90 |
| August 03, 2026 | 33.96 |
| July 31, 2026 | 33.98 |
| July 30, 2026 | 32.28 |
| July 29, 2026 | 31.78 |
| July 28, 2026 | 31.96 |
| July 27, 2026 | 31.82 |
| July 24, 2026 | 31.28 |
| July 23, 2026 | 32.81 |
| July 22, 2026 | 30.81 |
| July 21, 2026 | 30.04 |
| Date | Value |
|---|---|
| July 20, 2026 | 27.31 |
| July 17, 2026 | 29.55 |
| July 16, 2026 | 29.06 |
| July 15, 2026 | 29.91 |
| July 14, 2026 | 31.15 |
| July 13, 2026 | 29.63 |
| July 10, 2026 | 30.57 |
| July 09, 2026 | 30.36 |
| July 08, 2026 | 30.83 |
| July 07, 2026 | 30.35 |
| July 06, 2026 | 29.20 |
| July 02, 2026 | 29.58 |
| July 01, 2026 | 27.76 |
| June 30, 2026 | 27.37 |
| June 29, 2026 | 29.19 |
| June 26, 2026 | 28.80 |
| June 25, 2026 | 26.36 |
| June 24, 2026 | 27.32 |
| June 23, 2026 | 27.51 |
| June 22, 2026 | 27.54 |
| June 18, 2026 | 25.85 |
| June 17, 2026 | 26.03 |
| June 16, 2026 | 26.59 |
| June 15, 2026 | 25.01 |
| June 12, 2026 | 27.26 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Moderna, Inc. | 138.89 |
| Kailera Therapeutics, Inc. | 16.54 |
| Arrowhead Pharmaceuticals, Inc. | 86.73 |
| Oncolytics Biotech, Inc. | 0.8441 |
| Sangamo Therapeutics, Inc. | 0.16 |